Clover Health Investments 's Revenue in the fiscal year 2025 $ 1,924.31 millions
Clover Health Investments 's Revenue in the fiscal year 2024 $ 1,371.13 millions
Clover Health Investments 's Revenue in the fiscal year 2023 $ 2,033.72 millions
Clover Health Investments 's Revenue in the fiscal year 2022 $ 3,476.69 millions
Clover Health Investments 's Revenue in the fiscal year 2021 $ 1,472.00 millions
CLOV Revenue third quarter 2026 Y/Y Growth Comment
Clover Health Investments Corp achieved in the third quarter 2026, above Company average Revenue rise of 52.89% year on year, to $ 759.30 millions.
Looking into third quarter 2026 results within Accident & Health Insurance industry 7 other companies have achieved higher Revenue growth. While Clover Health Investments Corp ' s Revenue jump of 52.89% ranks overall at the positon no. 1565 in the third quarter 2026.
Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026
Clover Health Investments 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
105.9 %
11.82 %
-64.17 %
(Jun 30 2021)
CLOV's III. Quarter Q/Q Revenue Comment
Clover Health Investments Corp achieved in the III. Quarter 2026 below company average Revenue growth of 2.17% quarter on quarter, to $ 759.30 millions.
Within Accident & Health Insurance industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Clover Health Investments 's Revenue growth quarter on quarter, overall rank is 1936.
Clover Health Investments Corp achieved in the III. Quarter 2026 below company average Revenue growth of 2.17% quarter on quarter, to $ 759.30 millions.
Within Accident & Health Insurance industry 7 other companies have achieved higher Revenue quarter on quarter growth. While Clover Health Investments 's Revenue growth quarter on quarter, overall rank is 1936.
Clover Health Investments 's 12 Months Revenue Growth Year on Year
Clover Health Investments saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 54.03% year on year, to $ 2,477 millions if the fiscal year would have ended in Jun 30 2026. Clover Health Investments 's trailing twelve months Revenue growth was higher than company's average 4.24% and higher than 48.75% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 12.01 % from $2211.17 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 4.24%.
In the Financial sector 716 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2779 to 3222.
Clover Health Investments saw improvement in Revenue growth trend, posting cumulative 12 months Revenue growth of 54.03% year on year, to $ 2,477 millions if the fiscal year would have ended in Jun 30 2026. Clover Health Investments 's trailing twelve months Revenue growth was higher than company's average 4.24% and higher than 48.75% growth in Mar 31 2026. But from twelve months ended Mar 31 2026 rise was beneth at 12.01 % from $2211.17 millions achieved in the period from Mar 31 2026 to Jun 30 2025. Still this was evidence of convincing trend, while the usual Q/Q TTM gain stands at 4.24%. The momentum is even more impressive from twelve months ended Mar 31 2026 exhibited at 12.01 % increase from $2211.17 millions in the period from Mar 31 2026 to Jun 30 2025.
In the Financial sector 716 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2779 to 3222.
About Clover Health Investments Revenue Growth Rates (CLOV), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
What’s included here
Company: Clover Health Investments Corp
(CIK 1801170).
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
82.97%